Page last updated: 2024-12-05

methyl carbamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methyl carbamate : A carbamate ester resulting from the formal condensation of the carboxy group of carbamic acid with methanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11722
CHEMBL ID1085707
CHEBI ID76606
MeSH IDM0111953

Synonyms (60)

Synonym
methylurethane
wln: zvo1
methylurethan
nsc-3054
598-55-0
urethylane
nsc3054
methyl carbamate
nci-c55594
carbamic acid methyl ester
ccris 885
nsc 3054
methylcarbamate
ai3-11025
brn 0635779
hsdb 2587
methylester kyseliny karbaminove [czech]
einecs 209-939-2
methylkarbamat [czech]
carbamic acid, methyl ester
methyl carbamate, 98%
inchi=1/c2h5no2/c1-5-2(3)4/h1h3,(h2,3,4)
gtcaxtirrlkxru-uhfffaoysa-
chebi:76606 ,
CHEMBL1085707
AKOS000119823
C19445
cas-598-55-0
NCGC00255205-01
tox21_301388
dtxcid60834
dtxsid8020834 ,
BBL011430
STL146537
ec 209-939-2
4-03-00-00037 (beilstein handbook reference)
9wfx634x2t ,
unii-9wfx634x2t
methylester kyseliny karbaminove
methylkarbamat
FT-0628712
methoxycarbonylamine
meo2cnh2
h2nco2me
h2ncooch3
nh2co2me
methyl carbamate [hsdb]
methyl carbamate [mi]
methyl carbamate [iarc]
mfcd00007964
J-522596
D86342
methyl carbamate, vetec(tm) reagent grade, 98%
F0001-1570
Q5927934
STR08482
AMY4044
EN300-20079
CS-0017839
Z104476722

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Toxic alterations consisted of focal hepatocellular necrosis, pigmentation of Kupffer's cells, and the presence of basophilic inclusions resembling nucleoli in the cytoplasm of hepatocytes."( Thirteen-week oral toxicity study of methyl carbamate in rats and mice.
Chan, PC; Crawford, D; Hall, WC; Kanagalingam, KK; Quest, JA, 1987
)
0.55
"Malathion-induced marked potentiation of BPMC toxicity (about fivefold) was analyzed by measuring LD50 as an index of acute toxicity."( Contribution of monoaminergic nervous system in potentiation of 2-sec-butylphenyl N-methylcarbamate (BPMC) toxicity by malathion in male mice.
Shirasu, Y; Takahashi, H; Tanaka, J; Tsuda, S, 1987
)
0.27
"Carbofuran is one of the most toxic broad-spectrum and systemic N-methyl carbamate pesticide, which is extensively applied as insecticide, nematicide and acaricide for agricultural, domestic and industrial purposes."( Carbofuran toxicity and its microbial degradation in contaminated environments.
Bhatt, P; Chen, S; Huang, Y; Lin, Z; Mishra, S; Pang, S; Zhang, W, 2020
)
0.8

Dosage Studied

ExcerptRelevanceReference
" In contrast, exposure to the multipotential carcinogen, ethyl carbamate (urethan) at tumourigenic dosages caused severe myelotoxicity at all dosage levels."( Immune functions in methyl and ethyl carbamate treated mice.
Boorman, GA; Dean, JH; Dieter, MP; Hayes, HT; Luster, MI, 1982
)
0.26
" In-medium dosing with MMS produced a LOGEL of 20 µg/ml, which was very similar to the topical LOGEL when considering the total mass of MMS added."( Automation and validation of micronucleus detection in the 3D EpiDerm™ human reconstructed skin assay and correlation with 2D dose responses.
Chapman, KE; Doak, SH; Jenkins, GJ; Pfuhler, S; Thomas, AD; Wills, JW, 2014
)
0.4
" All test materials and controls were dosed orally by gavage."( p-Chloroaniline, t-butylhydroquinone, and methyl carbamate: Rat in vivo comet test, JaCVAM trial phase 4.2.
Barfield, W; Burlinson, B, 2015
)
0.68
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
progesterone receptorHomo sapiens (human)Potency68.58960.000417.946075.1148AID1346795
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1145377Drug absorption in intestine (unknown origin) assessed as mucosal loss1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Molecular connectivity. 6. Examination of the parabolic relationship between molecular connectivity and biological activity.
AID1134605Oil-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID482623Inhibition of human LAL at 10 uM after 30 mins by fluorescence assay2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics.
AID1145376Drug absorption in intestine (unknown origin) assessed as serosal transfer1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Molecular connectivity. 6. Examination of the parabolic relationship between molecular connectivity and biological activity.
AID1134606Et2O-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1145367Drug absorption in intestine (unknown origin) assessed as tissue-bound transfer1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Molecular connectivity. 6. Examination of the parabolic relationship between molecular connectivity and biological activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (72)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (31.94)18.7374
1990's5 (6.94)18.2507
2000's10 (13.89)29.6817
2010's24 (33.33)24.3611
2020's10 (13.89)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.81 (24.57)
Research Supply Index4.36 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index62.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (3.90%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other74 (96.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]